Drugs / Carbon C 11 Choline
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02397408 | Apr → Jun 2015 | prostate cancer | University of California, San Francisco | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Carbon C 11 Choline | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02397408 ↗ |
| Modality | Diagnostic / imaging agent | “Diagnostic procedures, such as 11C- and 18F-choline PET/MR” NCT02397408 ↗ |
| Route | Intravenous | “Given intravenously (IV) prior to imaging” NCT02397408 ↗ |